Pluripotency-associated transcription factors, including NANOG, Sox2 and OCT4, are known as regulators of cellular identity in ES cells (36) and have recently been identified in the epithelial malignancies of a variety of tissues (33,37), including prostate cancer (13,14,18). This evidence concerns the gene SOX2 and Familial prostate cancer.